Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage.
H E Jasin, J D Taurog
H E Jasin, J D Taurog
Published May 1, 1991
Citation Information: J Clin Invest. 1991;87(5):1531-1536. https://doi.org/10.1172/JCI115164.
View: Text | PDF
Research Article

Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage.

  • Text
  • PDF
Abstract

We recently observed that specific antibodies to type II collagen do not bind in appreciable amounts to the intact surface of articular cartilage, whereas antibodies to the minor collagen types V, VI, and IX do. These results suggest that the outermost cartilage surface layer prevented interaction of the antibodies with the major collagen type in articular cartilage. The present studies were designed to investigate the pathogenic mechanisms involved in the disruption of the cartilage surface layer in inflammatory arthritis. Articular cartilage obtained from rabbits undergoing acute antigen-induced arthritis of 72 h duration showed a significant increase in binding of anti-type II antibody to cartilage surfaces compared with normal control cartilage (P less than 0.01). Augmentation of anti-type II binding was also observed upon in vitro incubation of bovine articular slices or intact rabbit patellar cartilage for 1 h with human polymorphonuclear neutrophils (PMN), PMN lysates, or purified human PMN elastase. This increase was not inhibited by sodium azide, nor was it enhanced by incubation of cartilage with the strong oxidant hypochlorous acid. Chondrocyte-mediated matrix proteoglycan degradation in cartilage explants cultured in the presence of cytokines failed to increase antibody binding appreciably. The augmentation in antibody binding seen with PMN lysates was inhibited by the nonspecific serine-esterase inhibitor PMSF, but not by the divalent metal chelator EDTA. The elastase-specific inhibitor AAPVCMK also inhibited most of the PMN-induced increase in antibody binding, whereas the cathepsin G-specific inhibitor GLPCMK was much less effective. Incubation of intact cartilage with purified human PMN elastase indicated that this serine esterase could account for the increase in anti-type II collagen antibody binding to intact cartilage surfaces. These studies suggest that in an inflammatory response, PMN-derived elastase degrades the outer layer of articular cartilage, exposing epitopes on type II collagen. They also help clarify the pathogenic mechanisms involved in early articular cartilage damage in inflammatory joint diseases.

Authors

H E Jasin, J D Taurog

×

Total citations by year

Year: 2023 2021 2018 2016 2015 2014 2011 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 Total
Citations: 2 1 1 1 3 1 1 2 2 1 2 1 1 2 1 3 4 2 2 2 4 4 3 11 2 59
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (59)

Title and authors Publication Year
An injectable hydrogel to disrupt neutrophil extracellular traps for treating rheumatoid arthritis
Wang N, Ma J, Song W, Zhao C
Drug Delivery 2023
The role of fibromodulin in inflammatory responses and diseases associated with inflammation
Zhao F, Bai Y, Xiang X, Pang X
Frontiers in immunology 2023
Matrix metalloproteinase‐13 is fully activated by neutrophil elastase and inactivates its serpin inhibitor, alpha‐1 antitrypsin: Implications for osteoarthritis
DJ Wilkinson, AM Falconer, HL Wright, H Lin, K Yamamoto, K Cheung, SH Charlton, M del Carmen Arques, S Janciauskiene, R Refaie, KS Rankin, DA Young, AD Rowan
The FEBS journal 2021
Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model
H Cho, BJ Kim, SH Park, K Hasty, BH Min
International Journal of Nanomedicine 2018
Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring Arthroplasty
C Wanderling, J Liles, E Davis, D Schmitt, S Statz, N Guler, D Hoppensteadt, J Fareed, W Hopkinson
Clinical and Applied Thrombosis/Hemostasis 2016
B-cell epitope spreading and inflammation in a mouse model of arthritis is associated with a deficiency in reactive oxygen species production: Cellular immune response
I Khmaladze, A Saxena, KS Nandakumar, R Holmdahl
European Journal of Immunology 2015
Anti-type II collagen immune complex-induced granulocyte reactivity is associated with joint erosions in RA patients with anti-collagen antibodies
VA Manivel, A Sohrabian, MC Wick, M Mullazehi, LD Håkansson, J Rönnelid
Arthritis Research & Therapy 2015
Detection of early cartilage damage using targeted nanosomes in a post-traumatic osteoarthritis mouse model
H Cho, E Pinkhassik, V David, J Stuart, KA Hasty
Nanomedicine: Nanotechnology, Biology and Medicine 2015
A Single Functional Group Substitution in C5a Breaks B Cell and T Cell Tolerance and Protects Against Experimental Arthritis: 4NPA-Substituted C5a as Antiinflammatory Vaccine
C Kessel, KS Nandakumar, FB Peters, V Gauba, PG Schultz, R Holmdahl
Arthritis & Rheumatology 2014
Crystal structure of an arthritogenic anticollagen immune complex
D Dobritzsch, I Lindh, H Uysal, KS Nandakumar, H Burkhardt, G Schneider, R Holmdahl
Arthritis & Rheumatism 2011
Different amplifying mechanisms of interleukin-17 and interferon-γ in Fcγ receptor-mediated cartilage destruction in murine immune complex-mediated arthritis
LC Grevers, PL van Lent, MI Koenders, B Walgreen, AW Sloetjes, F Nimmerjahn, JS Verbeek, WB van Berg
Arthritis & Rheumatism 2009
Pharmacology and Therapeutics
BL Clarke, S Khosla
Pharmacology & Therapeutics 2009
Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta
WO Cooper, RA Fava, CA Gates, MA Cremer, AS Townes
Clinical & Experimental Immunology 2008
Translating basic research into clinical rheumatology
D der Woude, TW Huizinga
Best Practice & Research Clinical Rheumatology 2008
Type II collagen without adjuvant induces eosinophilic arthritis
R Bockermann, R Holmdahl
European Journal of Immunology 2007
Atypical Antineutrophil???Cytoplasmic Antibodies and Vasculitis-Like Syndrome With Aphthous Ulcer and Violaceous Pinnae after Retreatment With Propylthiouracil for Graves Disease
E Koller, JB Svoboda, F Jones, G Moore
The Endocrinologist 2006
Surface-bound anti–type II collagen–containing immune complexes induce production of tumor necrosis factor α, interleukin-1β, and interleukin-8 from peripheral blood monocytes via fcγ receptor IIA: A potential pathophysiologic mechanism for humoral anti–type II collagen immunity in arthritis
M Mullazehi, L Mathsson, J Lampa, J Rönnelid
Arthritis & Rheumatism 2006
Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis
KA Elsaid, GD Jay, ML Warman, DK Rhee, CO Chichester
Arthritis & Rheumatism 2005
Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis
AD Cook, R Gray, J Ramshaw, IR Mackay, MJ Rowley
Arthritis Research & Therapy 2004
Collagen Type II-Specific Monoclonal Antibody-Induced Arthritis in Mice
KS Nandakumar, L Svensson, R Holmdahl
The American Journal of Pathology 2003
Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix
K A Elsaid, G D Jay, C O Chichester
Osteoarthritis and Cartilage 2003
Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis
Nobuhito Kashiwagi, Minoru Nakano, Abby R Saniabadi, Masakazu Adachi, Toshikazu Yoshikawa
Inflammation 2002
Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective
JP Case
American Journal of Therapeutics 2001
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
FH Epstein, EH Choy, GS Panayi
New England Journal of Medicine 2001
Proteases produced by activated neutrophils are able to release soluble CD23 fragments endowed with proinflammatory effects
C Brignone, O Munoz, M Batoz, A Rouquette-Jazdanian, JL Cousin
The FASEB Journal 2001
Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors
BB Gowen, TK Borg, A Ghaffar, EP Mayer
Matrix Biology 2000
Macromolecular transport across the superficial layer of articular cartilage
M Uesugi, HE Jasin
Osteoarthritis and Cartilage 2000
Mechanisms of joint destruction in rheumatoid arthritis
HE Jasin
Journal of Orthopaedic Science 2000
Gelenkpathologie
W Mohr
2000
Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis
AR Moore, A Appelboam, K Kawabata, JA da Silva, D D'Cruz, G Gowland, DA Willoughby
Annals of the rheumatic diseases 1999
Composition of the Extracellular Matrix in Human Cricoarytenoid Joint Articular Cartilage
F PAULSEN, B TILLMANN
Archives of Histology and Cytology 1999
Possible correction of abnormal rheumatoid arthritis synovial cell function byjun D transfection in vitro
S Wakisaka, N Suzuki, N Saito, T Ochi, T Sakane
Arthritis & Rheumatism 1998
Immunity to type IX collagen in rodents: a study of type IX collagen for autoimmune and arthritogenic activities
MA Cremer, XJ Ye, K Terato, MM Griffiths, WC Watson, AH Kang
Clinical & Experimental Immunology 1998
Granulocytapheresis in the Treatment of Patients with Rheumatoid Arthritis
M Ohara, AR Saniabadi, S Kokuma, I Hirata, M Adachi, T Agishi, R Kasukawa
Artificial Organs 1997
Autoimmune hypothesis of acquired subglottic stenosis: lack of support at time of surgical repair in children
JP Stolovitzky, NW Todd, RT Cotton, WG Campbell
International Journal of Pediatric Otorhinolaryngology 1997
The inhibitory effects of antirheumatic drugs on the activity of human leukocyte elastase and cathepsin G
J Steinmeyer, DA Kalbhen
Inflammation Research 1996
Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1
J Fujimori, S Yoshino, M Koiwa, H Hirai, H Shiga, N Hayama, Y Iino
Rheumatology International 1996
Fibroblast adhesion to articular cartilage
HE Jasin, WD Blackburn, WW Chatham
Arthritis & Rheumatism 1996
Fibronectin synthesis in superficial and deep layers of normal articular cartilage
T Hayashi, E Abe, HE Jasin
Arthritis & Rheumatism 1996
Rheumatoid synovial fibroblast adhesion to human articular cartilage
L Mccurdy, WW Chatham, WD Blackburn
Arthritis & Rheumatism 1995
Structure and Function of the Articular Cartilage Surface
HE Jasin
Scandinavian Journal of Rheumatology 1995
Immunoglobulin deposits in synovial membrane and cartilage and phenotype analysis of chondrocyte antigens in sheep infected with the visna retrovirus
GD Harkiss, C Green, A Anderson, NJ Watt
Rheumatology International 1995
THE NEUTROPHIL IN RHEUMATOID ARTHRITIS
MH Pillinger, SB Abramson
Rheumatic diseases clinics of North America 1995
Germline-Encoded IgG Antibodies Bind Mouse Cartilage In Vivo: Epitope- and Idiotype-Specific Binding and Inhibition
JA Mo, A Scheynius, S Nilsson, R Holmdahl
Scandinavian Journal of Immunology 1994
Inhibition of human fibroblast adhesion by cartilage surface proteoglycans
K Noyori, HE Jasin
Arthritis & Rheumatism 1994
Agalactosyl glycoforms of IgG autoantibodies are pathogenic
TW Rademacher, P Williams, RA Dwek
Proceedings of the National Academy of Sciences 1994
Autoimmune Recognition of Cartilage Collagens
R Holmdahl, V Malmström, E Vuorio
Annals of Medicine 1993
Pathogenesis of rheumatoid arthritis
KL Sewell, DE Trentham
The Lancet 1993
Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis
RA Fava, C Gates, AS Townes
Clinical & Experimental Immunology 1993
Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits
A Matsukawa, S Ohkawara, T Maeda, K Takagi, M Yoshinaga
Clinical & Experimental Immunology 1993
Arachidonic acid metabolism in TNS-induced chronic and immunologic enteritis in rats, and the effect of 5-ASA
FJ Zijlstra, AP Dijk, N Selve, JH Wilson
Mediators of Inflammation 1993
Mechanism of pentoxifylline mediated down-regulation of killer lineage cell functions
RS Parhar, P Ernst, K Sheth, M Einspenner, S Al-Sedairy
Mediators of Inflammation 1993
Characteristics of anti-type ii collagen antibody binding to articular cartilage
HE Jasin, K Noyori, T Takagi, JD Taurog
Arthritis & Rheumatism 1993
Matrix Metalloproteinases: A Review
H Birkedal-Hansen, WG Moore, MK Bodden, LJ Windsor, B Birkedal-Hansen, A DeCarlo, JA Engler
Critical Reviews in Oral Biology & Medicine 1993
Role of cytokines and inflammatory mediators in tissue destruction
H Birkedal-Hansen
Journal of Periodontal Research 1993
Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis.
Fava RA, Gates C, Townes AS
Clinical & Experimental Immunology 1993
Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits.
Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M
Clinical & Experimental Immunology 1993
Interactions Between Anticollagen Antibodies and Chondrocytes
T Takagi, HE Jasin
Arthritis & Rheumatism 1992
Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta.
Cooper WO, Fava RA, Gates CA, Cremer MA, Townes AS
Clinical & Experimental Immunology 1992

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts